Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for SAR446523, an ...

Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma Designation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment ...

The global infectious disease treatment market is projected to grow from $72.5 billion in 2025 to $101 billion by 2030, with ...

Sanofi's SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma <li /> Designation grante ...

A healthcare-focused panel discussion at this year’s Sapics Conference in Cape Town spotlighted Africa’s emergence as a ...

Itching is often the most debilitating cutaneous symptom of CKD and ESRD. Experts recommend a stepwise treatment approach ...

Thermo Fisher Scientific is a global science and diagnostics company serving pharmaceutical, biotechnology, healthcare, academic, and government customers. It is known for instruments, chemicals, and ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Against steep odds and well-established paradigms, these four companies have successfully been commercializing their products ...

After our editorial, the agency relents to allow a Duchenne treatment.

Owing to Briumvi's solid launch, TG's balance sheet is in excellent condition. Despite new competition, Briumvi's five-year ...